Aquestive Therapeutics Inc (AQST) earnings · rev $44.5M
These earnings events as JSON? API free 100/dayAquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
This AQST earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AQST revenue for 2025-12-31 was $44.5M. Net income was -$83.8M. Revenue was down 22.6% from 2024-12-31 to 2025-12-31. AQST currently screens at market cap $493.0M.
When the next AQST 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 22.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AQST research stays on the stock page; the tape stays on the quote page.
AQST earnings FAQ
What are AQST's latest revenue and net income?
Latest cached Aquestive Therapeutics Inc (AQST) revenue for Dec 31, 2025 was $44.5M. Net income was -$83.8M. Statements: https://lician.com/financials/aqst
What is AQST's latest diluted EPS?
Latest cached Aquestive Therapeutics Inc (AQST) diluted EPS for Dec 31, 2025 was -$0.78.
What period does the latest AQST earnings print cover?
The latest cached Aquestive Therapeutics Inc (AQST) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did AQST revenue change from the prior cached period?
Cached Aquestive Therapeutics Inc (AQST) revenue was down 22.6% from $57.6M (Dec 31, 2024) to $44.5M (Dec 31, 2025). Statements: https://lician.com/financials/aqst
Where are AQST earnings listed?
Cached earnings facts for Aquestive Therapeutics Inc (AQST) are listed at https://lician.com/earnings/aqst. Statements: https://lician.com/financials/aqst
Not investment advice.